Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 26% ± 5% | |
GABAergic neuron | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 1394.34 | 243 / 245 | 96% | 17.83 | 482 / 502 |
lung | 93% | 623.76 | 537 / 578 | 95% | 8.81 | 1102 / 1155 |
uterus | 100% | 3201.64 | 170 / 170 | 87% | 16.41 | 399 / 459 |
bladder | 100% | 3330.95 | 21 / 21 | 84% | 7.17 | 425 / 504 |
thymus | 99% | 968.28 | 649 / 653 | 85% | 10.18 | 512 / 605 |
ovary | 97% | 792.11 | 175 / 180 | 85% | 5.41 | 366 / 430 |
intestine | 87% | 2875.78 | 840 / 966 | 94% | 7.92 | 494 / 527 |
esophagus | 83% | 1233.24 | 1196 / 1445 | 95% | 7.95 | 174 / 183 |
breast | 80% | 392.53 | 369 / 459 | 93% | 9.94 | 1045 / 1118 |
brain | 63% | 270.78 | 1660 / 2642 | 97% | 9.83 | 684 / 705 |
skin | 71% | 847.64 | 1283 / 1809 | 86% | 7.46 | 406 / 472 |
stomach | 60% | 777.89 | 217 / 359 | 92% | 10.43 | 264 / 286 |
adrenal gland | 65% | 255.34 | 168 / 258 | 77% | 4.63 | 177 / 230 |
kidney | 36% | 171.17 | 32 / 89 | 76% | 4.40 | 681 / 901 |
blood vessel | 100% | 2812.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 91% | 666.68 | 1097 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 2% | 8.68 | 8 / 328 | 84% | 6.58 | 150 / 178 |
tonsil | 0% | 0 | 0 / 0 | 84% | 6.87 | 38 / 45 |
heart | 68% | 408.43 | 587 / 861 | 0% | 0 | 0 / 0 |
muscle | 68% | 306.29 | 544 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 1.15 | 12 / 29 |
liver | 2% | 5.34 | 4 / 226 | 28% | 1.06 | 112 / 406 |
eye | 0% | 0 | 0 / 0 | 21% | 0.63 | 17 / 80 |
peripheral blood | 13% | 45.45 | 118 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 4.86 | 4 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060271 | Biological process | cilium assembly |
GO_0000045 | Biological process | autophagosome assembly |
GO_0046039 | Biological process | GTP metabolic process |
GO_0042308 | Biological process | negative regulation of protein import into nucleus |
GO_0006886 | Biological process | intracellular protein transport |
GO_0006968 | Biological process | cellular defense response |
GO_0097094 | Biological process | craniofacial suture morphogenesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0012505 | Cellular component | endomembrane system |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005776 | Cellular component | autophagosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0030054 | Cellular component | cell junction |
GO_0010008 | Cellular component | endosome membrane |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB23 |
Protein name | Ras-related protein Rab-23 |
Synonyms | HSPC137 |
Description | FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. Together with SUFU, prevents nuclear import of GLI1, and thereby inhibits GLI1 transcription factor activity. Regulates GLI1 in differentiating chondrocytes. Likewise, regulates GLI3 proteolytic processing and modulates GLI2 and GLI3 transcription factor activity. Plays a role in autophagic vacuole assembly, and mediates defense against pathogens, such as S.aureus, by promoting their capture by autophagosomes that then merge with lysosomes. . |
Accessions | Q9ULC3 ENST00000468148.6 ENST00000317483.4 |